Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Literature
1.
Dünnebier T, Schlaefer K, Gilbert M, Baisch C, Justenhoven C, Brauch H, Harth V, Spickenheuer A, Rabstein S, Pesch B, Brüning T, Ko YD, Hamann U (2010) No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk. Breast Cancer Res Treat. doi 10.​1007/​s10549-010-1194-3
2.
Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O’Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R (2010) Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study. J Natl Cancer Inst 102:1422–1431CrossRefPubMedPubMedCentral
3.
Key J, Hodgson S, Omar RZ, Jensen TK, Thompson SG, Boobis AR, Davies DS, Elliott P (2006) Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 17:570–759CrossRef
4.
van Wieren-de Wijer DB, Maitland-van der Zee AH, de Boer A, Kroon AA, de Leeuw PW, Schiffers P, Janssen RG, Psaty BM, van Duijn CM, Stricker BH, Klungel OH (2009) Reasons for non-response in observational pharmacogenetic research. Pharmacoepidemiol Drug Saf 8:665–671CrossRef
1.
Dünnebier T, Schlaefer K, Gilbert M, Baisch C, Justenhoven C, Brauch H, Harth V, Spickenheuer A, Rabstein S, Pesch B, Brüning T, Ko YD, Hamann U (2010) No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk. Breast Cancer Res Treat. doi 10.​1007/​s10549-010-1194-3
Metadata
Title
No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk in German population
Authors
Chun Zhang
Ping Zhou
Jian-Ping Li
Publication date
01-02-2011
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2011
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-1253-9

Other articles of this Issue 1/2011

Breast Cancer Research and Treatment 1/2011 Go to the issue

Clinical trial

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)

Epidemiology

Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study

Preclinical study

Role of ferritin alterations in human breast cancer cells

Clinical trial

Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer

Clinical trial

Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia

Epidemiology

Effects of breast cancer surgery and surgical side effects on body image over time
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits